Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U ...

The first-line laser treatment for glaucoma and ocular hypertension will be unveiled at the 2025 American Glaucoma Society ...

Alcon (ALC) announced he full U.S. commercial availability of Voyager DSLT, the first and only Direct Selective Laser Trabeculoplasty device .

Traditional SLT involves using a laser to manipulate the eye's trabecular meshwork, located around the base of the cornea, ...

Direct selective laser trabeculoplasty enhances the experience for both patients and physicians, he notes, while also ...

Voyager DSLT has been embraced by my staff and is easy to implement, allowing me to treat more of my patients with a recognized first-line standard in glaucoma treatment.” Glaucoma is a ...

Alcon introduces Voyager DSLT in US for the treatment for glaucoma and ocular hypertension: Geneva Thursday, February 20, 2025, 14:00 Hrs [IST] Alcon, the global leader in eye car ...

Voyager DSLT is uniquely poised to accelerate the adoption of laser as a first-line therapy, unlocking the treatment’s availability for more patients. Designed for an exceptional patient and ...

New first-line laser treatment for the nearly 5 million Americans diagnosed with glaucoma 1,2 Automated device enables a streamlined workflow without a gonio lens or manual aiming 2 Voyager Direct ...